<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <title>BRM.V</title>
  <style>
    /* Default styles provided by pandoc.
    ** See https://pandoc.org/MANUAL.html#variables-for-html for config info.
    */
    html {
      color: #1a1a1a;
      background-color: #fdfdfd;
    }
    body {
      margin: 0 auto;
      max-width: 36em;
      padding-left: 50px;
      padding-right: 50px;
      padding-top: 50px;
      padding-bottom: 50px;
      hyphens: auto;
      overflow-wrap: break-word;
      text-rendering: optimizeLegibility;
      font-kerning: normal;
    }
    @media (max-width: 600px) {
      body {
        font-size: 0.9em;
        padding: 12px;
      }
      h1 {
        font-size: 1.8em;
      }
    }
    @media print {
      html {
        background-color: white;
      }
      body {
        background-color: transparent;
        color: black;
        font-size: 12pt;
      }
      p, h2, h3 {
        orphans: 3;
        widows: 3;
      }
      h2, h3, h4 {
        page-break-after: avoid;
      }
    }
    p {
      margin: 1em 0;
    }
    a {
      color: #1a1a1a;
    }
    a:visited {
      color: #1a1a1a;
    }
    img {
      max-width: 100%;
    }
    svg {
      height: auto;
      max-width: 100%;
    }
    h1, h2, h3, h4, h5, h6 {
      margin-top: 1.4em;
    }
    h5, h6 {
      font-size: 1em;
      font-style: italic;
    }
    h6 {
      font-weight: normal;
    }
    ol, ul {
      padding-left: 1.7em;
      margin-top: 1em;
    }
    li > ol, li > ul {
      margin-top: 0;
    }
    blockquote {
      margin: 1em 0 1em 1.7em;
      padding-left: 1em;
      border-left: 2px solid #e6e6e6;
      color: #606060;
    }
    code {
      font-family: Menlo, Monaco, Consolas, 'Lucida Console', monospace;
      font-size: 85%;
      margin: 0;
      hyphens: manual;
    }
    pre {
      margin: 1em 0;
      overflow: auto;
    }
    pre code {
      padding: 0;
      overflow: visible;
      overflow-wrap: normal;
    }
    .sourceCode {
     background-color: transparent;
     overflow: visible;
    }
    hr {
      border: none;
      border-top: 1px solid #1a1a1a;
      height: 1px;
      margin: 1em 0;
    }
    table {
      margin: 1em 0;
      border-collapse: collapse;
      width: 100%;
      overflow-x: auto;
      display: block;
      font-variant-numeric: lining-nums tabular-nums;
    }
    table caption {
      margin-bottom: 0.75em;
    }
    tbody {
      margin-top: 0.5em;
      border-top: 1px solid #1a1a1a;
      border-bottom: 1px solid #1a1a1a;
    }
    th {
      border-top: 1px solid #1a1a1a;
      padding: 0.25em 0.5em 0.25em 0.5em;
    }
    td {
      padding: 0.125em 0.5em 0.25em 0.5em;
    }
    header {
      margin-bottom: 4em;
      text-align: center;
    }
    #TOC li {
      list-style: none;
    }
    #TOC ul {
      padding-left: 1.3em;
    }
    #TOC > ul {
      padding-left: 0;
    }
    #TOC a:not(:hover) {
      text-decoration: none;
    }
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    /* The extra [class] is a hack that increases specificity enough to
       override a similar rule in reveal.js */
    ul.task-list[class]{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      font-size: inherit;
      width: 0.8em;
      margin: 0 0.8em 0.2em -1.6em;
      vertical-align: middle;
    }
    .display.math{display: block; text-align: center; margin: 0.5rem auto;}
  </style>
</head>
<body>
<h1 id="biorem-inc.-brm.v">BIOREM Inc. (BRM.V)</h1>
<h2 id="business-summary">Business summary</h2>
<ul>
<li>Clean technology company designing and manufacturing biological air
emission control systems for odor, VOC and HAP removal, plus biogas
conditioning.</li>
<li>Core market: North American municipal wastewater; global footprint
via reps, with manufacturing and sales in North America and China.</li>
<li>Over 2,000 installed systems; custom engineered solutions with
dedicated service and support.</li>
<li>R&amp;D focus on media technologies and biological treatment of
hydrogen sulfide.</li>
</ul>
<h2 id="recent-developments">Recent developments</h2>
<ul>
<li>Q2 2025 revenue rose 29% YoY to $9.43M; gross margin expanded to
~27% (vs ~22.7% in Q2 2024).</li>
<li>H1 2025 bookings reached $24.1M (+27% YoY), with Q2 bookings of
$7.4M; backlog at quarter-end was $60.9M (+$3.9M YoY).</li>
<li>Q2 2025 G&amp;A included a $411k provision for potential
uncollectability on a specific project with funding issues.</li>
<li>Cash decreased to $7.66M (from $9.60M at Mar 31, 2025) as working
capital absorbed cash; Q2 operating cash flow was -$1.34M; capex of
$0.25M.</li>
<li>Project execution improved despite logistics/geopolitical/tariff
headwinds; management expects continued revenue conversion from backlog
over the next ~18 months.</li>
</ul>
<h2 id="key-issues">Key issues</h2>
<ul>
<li>Backlog conversion and customer scheduling drive quarterly
volatility; long sales cycles can cause revenue and cash flow
swings.</li>
<li>Customer payment delays/default risk can pressure liquidity;
fixed-price contract risk if actual costs exceed estimates.</li>
<li>Dependence on subcontractors for field construction, and ongoing
exposure to FX (US-dollar monetary assets ~US$5.8M at June 30,
2025).</li>
<li>Product development and market acceptance risks for new media
technologies; low share-trading liquidity can amplify price moves.</li>
</ul>
<h2 id="financial-summary-cad-000s">Financial summary (CAD ‘000s)</h2>
<table>
<colgroup>
<col style="width: 57%" />
<col style="width: 10%" />
<col style="width: 10%" />
<col style="width: 10%" />
<col style="width: 10%" />
</colgroup>
<thead>
<tr>
<th>Metric (CAD ‘000s)</th>
<th style="text-align: right;">Q2 2025</th>
<th style="text-align: right;">Q2 2024</th>
<th style="text-align: right;">H1 2025</th>
<th style="text-align: right;">H1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>Revenue</td>
<td style="text-align: right;">9,431</td>
<td style="text-align: right;">7,300</td>
<td style="text-align: right;">14,161</td>
<td style="text-align: right;">13,218</td>
</tr>
<tr>
<td>Gross Profit</td>
<td style="text-align: right;">2,550</td>
<td style="text-align: right;">1,657</td>
<td style="text-align: right;">3,660</td>
<td style="text-align: right;">3,437</td>
</tr>
<tr>
<td>Operating Income (EBIT)</td>
<td style="text-align: right;">1,054</td>
<td style="text-align: right;">512</td>
<td style="text-align: right;">1,148</td>
<td style="text-align: right;">1,028</td>
</tr>
<tr>
<td>EBITDA (est., per company definition)</td>
<td style="text-align: right;">1,177</td>
<td style="text-align: right;">591</td>
<td style="text-align: right;">1,375</td>
<td style="text-align: right;">1,222</td>
</tr>
<tr>
<td>Adjusted EBITDA</td>
<td style="text-align: right;">n/a</td>
<td style="text-align: right;">n/a</td>
<td style="text-align: right;">n/a</td>
<td style="text-align: right;">n/a</td>
</tr>
<tr>
<td>Finance costs / Interest expense</td>
<td style="text-align: right;">41</td>
<td style="text-align: right;">50</td>
<td style="text-align: right;">84</td>
<td style="text-align: right;">101</td>
</tr>
<tr>
<td>Net Income</td>
<td style="text-align: right;">745</td>
<td style="text-align: right;">340</td>
<td style="text-align: right;">782</td>
<td style="text-align: right;">681</td>
</tr>
<tr>
<td>Cash generated from operating activities</td>
<td style="text-align: right;">(1,337)</td>
<td style="text-align: right;">(1,860)</td>
<td style="text-align: right;">3,359</td>
<td style="text-align: right;">2,280</td>
</tr>
<tr>
<td>Capital expenditures (capex)</td>
<td style="text-align: right;">249</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">340</td>
<td style="text-align: right;">367</td>
</tr>
<tr>
<td>Free Cash Flow (CFO − capex)</td>
<td style="text-align: right;">(1,586)</td>
<td style="text-align: right;">(1,863)</td>
<td style="text-align: right;">3,019</td>
<td style="text-align: right;">1,913</td>
</tr>
<tr>
<td>Order bookings</td>
<td style="text-align: right;">7,400</td>
<td style="text-align: right;">13,000</td>
<td style="text-align: right;">24,100</td>
<td style="text-align: right;">19,100</td>
</tr>
<tr>
<td>Order backlog (end of period)</td>
<td style="text-align: right;">60,900</td>
<td style="text-align: right;">57,000</td>
<td style="text-align: right;">60,900</td>
<td style="text-align: right;">57,000</td>
</tr>
<tr>
<td>Working capital (end of period)</td>
<td style="text-align: right;">10,016</td>
<td style="text-align: right;">7,590</td>
<td style="text-align: right;">10,016</td>
<td style="text-align: right;">7,590</td>
</tr>
<tr>
<td>Cash and cash equivalents (end of period)</td>
<td style="text-align: right;">7,655</td>
<td style="text-align: right;">3,904</td>
<td style="text-align: right;">7,655</td>
<td style="text-align: right;">3,904</td>
</tr>
</tbody>
</table>
<p>Notes:</p>
<ul>
<li>Sources: Company MD&amp;A and unaudited condensed consolidated
interim financial statements for the three and six months ended June 30,
2025 and 2024 (all figures in CAD).</li>
<li>Operating income (EBIT) = Gross Profit − Total operating expenses
(which include Sales &amp; Marketing, R&amp;D, G&amp;A, and Other
expense/income).</li>
<li>EBITDA per company definition: earnings from operations before
interest, taxes, FX gains/losses, depreciation and amortization.
Approximations:
<ul>
<li>Q2 2025: EBIT 1,053.8 + D&amp;A ≈ 122 + add-back FX loss ≈ 0.6 ≈
1,177.</li>
<li>Q2 2024: EBIT 512.5 + D&amp;A ≈ 74 + add-back FX loss ≈ 4.0 ≈
591.</li>
<li>H1 2025: EBIT 1,148 − FX income 17.1 + D&amp;A 243.6 ≈ 1,375.</li>
<li>H1 2024: EBIT 1,028 + D&amp;A 148.5 + FX loss 45.5 ≈ 1,222.</li>
</ul></li>
<li>Depreciation and amortization available only for H1 periods (H1
2025: 243.6; H1 2024: 148.5). Quarterly D&amp;A for Q2 2025 and Q2 2024
are estimated as roughly half of the respective H1 amounts.</li>
<li>Cash from operating activities:
<ul>
<li>Quarterly: from MD&amp;A “sources and uses” table (Q2 2025: -1,337;
Q2 2024: -1,860).</li>
<li>H1: reconciled to MD&amp;A and cash flow statement totals (H1 2025 ≈
4,695 − 1,337 = 3,359; H1 2024 ≈ 2,280 per cash flow statement).</li>
</ul></li>
<li>Capex:
<ul>
<li>Quarterly: MD&amp;A (Q2 2025: 249; Q2 2024: 3).</li>
<li>H1: cash flow statement (H1 2025: 340; H1 2024: 367).</li>
</ul></li>
<li>Free Cash Flow = CFO − capex (approximation, as requested).</li>
<li>Order bookings and backlog:
<ul>
<li>Q2 2025 bookings $7.4m; H1 2025 bookings $24.1m (vs. $19.1m H1
2024).</li>
<li>Backlog at period-end: $60.9m (June 30, 2025) vs. $57.0m (June 30,
2024).</li>
</ul></li>
<li>Working capital and cash balances are at June 30 period-ends.</li>
<li>The “Selected Quarterly Information” block in the MD&amp;A appears
inconsistently extracted; figures herein rely on the detailed interim
statements and explicit MD&amp;A sections for accuracy.</li>
</ul>
<table>
<thead>
<tr>
<th>Metric (CAD ‘000s)</th>
<th style="text-align: right;">FY 2024</th>
<th style="text-align: right;">FY 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>Revenue</td>
<td style="text-align: right;">37,419</td>
<td style="text-align: right;">25,165</td>
</tr>
<tr>
<td>Gross Profit</td>
<td style="text-align: right;">10,056</td>
<td style="text-align: right;">7,022</td>
</tr>
<tr>
<td>Operating Income (EBIT)</td>
<td style="text-align: right;">4,344</td>
<td style="text-align: right;">3,063</td>
</tr>
<tr>
<td>EBITDA (est., per company definition)</td>
<td style="text-align: right;">4,867</td>
<td style="text-align: right;">3,469</td>
</tr>
<tr>
<td>Finance costs / Interest expense</td>
<td style="text-align: right;">195</td>
<td style="text-align: right;">273</td>
</tr>
<tr>
<td>Net Income</td>
<td style="text-align: right;">3,044</td>
<td style="text-align: right;">2,179</td>
</tr>
<tr>
<td>Cash generated from operating activities</td>
<td style="text-align: right;">3,685</td>
<td style="text-align: right;">490</td>
</tr>
<tr>
<td>Capital expenditures (capex)</td>
<td style="text-align: right;">372</td>
<td style="text-align: right;">553</td>
</tr>
<tr>
<td>Free Cash Flow (CFO − capex)</td>
<td style="text-align: right;">3,313</td>
<td style="text-align: right;">(63)</td>
</tr>
<tr>
<td>Order bookings</td>
<td style="text-align: right;">41,300</td>
<td style="text-align: right;">36,500</td>
</tr>
<tr>
<td>Order backlog (end of period)</td>
<td style="text-align: right;">56,100</td>
<td style="text-align: right;">50,100</td>
</tr>
<tr>
<td>Working capital (end of period)</td>
<td style="text-align: right;">9,421</td>
<td style="text-align: right;">6,710</td>
</tr>
<tr>
<td>Cash and cash equivalents (end of period)</td>
<td style="text-align: right;">5,213</td>
<td style="text-align: right;">2,292</td>
</tr>
</tbody>
</table>
<h2 id="capitalization-cash-debt-and-enterprise-value">Capitalization,
Cash, Debt, and Enterprise Value</h2>
<table>
<thead>
<tr>
<th>Item</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Stock Price</td>
<td>$2.03 CAD</td>
</tr>
<tr>
<td>Basic Shares</td>
<td>16,029,727</td>
</tr>
<tr>
<td>Fully Diluted Shares (per diluted EPS)</td>
<td>18,605,749</td>
</tr>
<tr>
<td>Implied Market Cap (Basic)</td>
<td>$32.54m</td>
</tr>
<tr>
<td>Implied Market Cap (Fully Diluted)</td>
<td>$37.77m</td>
</tr>
<tr>
<td>Cash (Jun 30, 2025)</td>
<td>$7.66m</td>
</tr>
<tr>
<td>Debt – Interest-bearing loans (Jun 30, 2025)</td>
<td>$2.15m</td>
</tr>
<tr>
<td>Net Cash (Cash − Debt)</td>
<td>$5.51m</td>
</tr>
<tr>
<td>EV (Basic, excl. leases)</td>
<td>$27.03m</td>
</tr>
<tr>
<td>EV (Fully Diluted, excl. leases)</td>
<td>$32.26m</td>
</tr>
<tr>
<td>Lease Liabilities (Jun 30, 2025)</td>
<td>$0.99m</td>
</tr>
<tr>
<td>EV (Basic, incl. leases)</td>
<td>$28.03m</td>
</tr>
<tr>
<td>EV (Fully Diluted, incl. leases)</td>
<td>$33.25m</td>
</tr>
</tbody>
</table>
<p>Notes:</p>
<ul>
<li>Sources: Company MD&amp;A and unaudited condensed consolidated
interim financial statements for the period ended June 30, 2025 (all
CAD).</li>
<li>Share counts:
<ul>
<li>Basic shares: 16,029,727 (per Note 10 EPS table for Q2 2025).</li>
<li>Fully diluted shares: 18,605,749 (basic + dilutive options per Note
10 EPS table for Q2 2025). This reflects the treasury stock method used
in diluted EPS, not a gross “all options exercised” figure.</li>
<li>MD&amp;A “Outstanding Share Data” table also references 3,295,000
options outstanding and shows 16,137,437 common shares; however, cash
flow statements show no option exercises in H1’25 and EPS note uses
16,029,727. I use 16,029,727 as the most reliable period figure and the
diluted count from the EPS note.</li>
</ul></li>
<li>Market capitalization calculations:
<ul>
<li>Implied Market Cap (Basic) = 16,029,727 × $2.03 = $32,540,346.</li>
<li>Implied Market Cap (FD) = 18,605,749 × $2.03 = $37,769,670.</li>
</ul></li>
<li>Cash and debt:
<ul>
<li>Cash: $7,655,436 at June 30, 2025.</li>
<li>Interest-bearing term loan: ~$2,146,718 carrying amount at June 30,
2025 (MD&amp;A maturity analysis; Note 7 discloses a similar $2.145m
term loan total). Net cash ≈ $7.655m − $2.147m = $5.51m.</li>
<li>Lease liabilities: ~$0.994m total (current ~$0.083m, non-current
~$0.910m).</li>
</ul></li>
<li>Enterprise Value:
<ul>
<li>EV (excl. leases) = Market Cap + Interest-bearing Debt − Cash.
<ul>
<li>Basic EV = $32.54m + $2.15m − $7.66m ≈ $27.03m.</li>
<li>FD EV = $37.77m + $2.15m − $7.66m ≈ $32.26m.</li>
</ul></li>
<li>EV (incl. leases) adds lease liabilities to debt:
<ul>
<li>Basic EV incl. leases ≈ $32.54m + ($2.15m + $0.99m) − $7.66m ≈
$28.03m.</li>
<li>FD EV incl. leases ≈ $37.77m + ($2.15m + $0.99m) − $7.66m ≈
$33.25m.</li>
</ul></li>
</ul></li>
<li>No pro forma adjustments post quarter-end: The MD&amp;A states there
were no material changes to outstanding share data from June 30, 2025 to
the MD&amp;A date, and no disclosed post-quarter changes to cash/debt;
therefore, no PF adjustments were applied.</li>
<li>If option exercise prices were provided, the treasury stock method
could adjust FD share count and add option proceeds to cash for EV;
absent strike data, the diluted EPS share count is used without proceeds
adjustment.</li>
</ul>
<h2 id="valuation">Valuation</h2>
<table>
<thead>
<tr>
<th>Metric</th>
<th>Basic</th>
<th>Fully Diluted</th>
</tr>
</thead>
<tbody>
<tr>
<td>EV/EBIT</td>
<td>6.28x</td>
<td>7.45x</td>
</tr>
<tr>
<td>EV/adjusted EBITDA</td>
<td>5.59x</td>
<td>6.62x</td>
</tr>
<tr>
<td>EV/unlevered FCF</td>
<td>6.10x</td>
<td>7.24x</td>
</tr>
</tbody>
</table>
<p>Notes:</p>
<ul>
<li>LTM period reference: LTM through June 30, 2025 calculated as FY
2024 + H1 2025 − H1 2024.</li>
<li>LTM EBIT (CAD m): 4.344 + 1.148 − 1.028 = 4.464.</li>
<li>Adjusted EBITDA methodology: company “EBITDA” is earnings from
operations before interest, taxes, FX, depreciation and amortization.
Thus, Adjusted EBITDA = EBIT + D&amp;A ± FX adjustment (add back FX
losses, subtract FX gains).
<ul>
<li>FY 2024 Adjusted EBITDA (CAD m): 4.344 + 0.473 + 0.050 = 4.867.</li>
<li>FY 2023 Adjusted EBITDA (CAD m): 3.063 + 0.383 + 0.024 = 3.469.</li>
<li>H1 2025 Adjusted EBITDA (CAD m): 1.375 (per Financial summary).</li>
<li>H1 2024 Adjusted EBITDA (CAD m): 1.222 (per Financial summary).</li>
<li>LTM Adjusted EBITDA (CAD m): 4.867 + 1.375 − 1.222 = 5.020.</li>
</ul></li>
<li>LTM Free Cash Flow (FCF) (CAD m): FY 2024 FCF 3.313 + H1 2025 FCF
3.019 − H1 2024 FCF 1.913 = 4.419.</li>
<li>LTM Finance costs (CAD m): 0.195 + 0.084 − 0.101 = 0.178.</li>
<li>LTM Unlevered FCF (CAD m): 4.419 + 0.178 = 4.597.</li>
<li>Enterprise Value used: EV including leases as of June 30, 2025
(Basic: $28.03m; Fully Diluted: $33.25m) from Capitalization
section.</li>
<li>Multiple calculations:
<ul>
<li>EV/EBIT (Basic): 28.03 / 4.464 = 6.28x; (FD): 33.25 / 4.464 =
7.45x.</li>
<li>EV/Adjusted EBITDA (Basic): 28.03 / 5.020 = 5.59x; (FD): 33.25 /
5.020 = 6.62x.</li>
<li>EV/Unlevered FCF (Basic): 28.03 / 4.597 = 6.10x; (FD): 33.25 / 4.597
= 7.24x.</li>
</ul></li>
<li>Units: Income statement and cash flow items are shown in CAD
millions in this section for compactness; underlying Financial summary
tables use CAD thousands.</li>
<li>Sources for annual figures: Audited Consolidated Financial
Statements and MD&amp;A for years ended December 31, 2024 and 2023.</li>
</ul>
</body>
</html>
